Genome sequencing

#Cancer Research Horizons #Genome sequencing #RNA sequencing #UK

Oesophageal cancer dataset made available for commercial use 

Cancer Research Horizons has made one the largest oesophageal cancer datasets available for commercial licensing.  Developed by a team led by Professor Rebecca Fitzgerald at the University of Cambridge, the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) dataset represents one of the world’s largest and most comprehensive collections… Read More

#Cancer Research #News

#Bacteria #Genome sequencing #Vaccines

Vaccine could be developed for H. influenzae bacteria, study shows 

Scientists believe a vaccine could be developed to tackle Haemophilus influenzae (H. influenzae) bacteria, which causes up to 200 million childhood infections each year.  An international team including researchers at the Wellcome Sanger Institute, the University of Oslo, the University of Oxford and the Shoklo Malaria Research Unit at Mahidol University in Thailand, found… Read More

#News

#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA #Webinar

How can long-read nanopore sequencing support gene therapy delivery?

Join DDW for this exclusive free event, ‘rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities’. The event will be supported by Oxford Nanopore Technologies. The event will feature experts Daniel Jachimowicz, Senior Bioscience Scientist at AstraZeneca BioPharmaceuticals R&D, Sweden,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA #Webinar

Uncovering packaging impurities with rAAV genome sequencing

Join DDW for this exclusive free event, ‘rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities’. The event will be supported by Oxford Nanopore Technologies. The event will feature experts Daniel Jachimowicz, Senior Bioscience Scientist at AstraZeneca BioPharmaceuticals R&D, Sweden,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

Gene sequence
#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA

How rAAV genome sequencing uncovers transgene integrity

Join DDW for this exclusive free event, ‘rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities’. The event will be supported by Oxford Nanopore Technologies. The event will feature experts Daniel Jachimowicz, Senior Bioscience Scientist at AstraZeneca BioPharmaceuticals R&D, Sweden,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA

DDW event focusses on rAAVs and long-read nanopore sequencing

Join DDW for this exclusive free event, ‘rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities’. The event will be supported by Oxford Nanopore Technologies. The event will feature experts Daniel Jachimowicz, Senior Bioscience Scientist at AstraZeneca BioPharmaceuticals R&D, Sweden,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA

rAAV Genome sequencing uncovers transgene integrity and packaging impurities

Recombinant adeno-associated viruses (rAAVs) are considered a promising delivery system for gene therapy medicines. This webinar highlights how long-read nanopore sequencing as a comprehensive and sensitive QC method for rAAVs were evaluated — which is supporting internal research activities at AstraZeneca. You will hear how library preparation, assessed data quality,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#Webinars

#Biobanking #Genome sequencing #Genomics #PacBio #Public health #Whole genome sequencing

Estonia National Biobank to sequence 10,000 whole genomes 

PacBio has announced that the University of Tartu, host of Estonia’s National Biobank, has chosen the company’s Revio HiFi sequencing system to sequence 10,000 whole human genomes and unlock new insights from its population health data.    The announcement follows funding from the European Commission and… Read More

#News

#Data #Drug development #Gene sequencing #Genome sequencing #Genomics #Healthcare #Precision medicine #Trusted research environment

Why Trusted Research Environments are key to the future of genomics  

Genomics is driving a revolution in drug development and, in the long run, the state of public healthcare. Advances in sequencing are leading to scientific breakthroughs in preventative care, faster diagnoses, and proactive medical interventions. Jack Dix, Head of Healthcare Strategy and Consulting at Kainos, expands.  Genetic… Read More

#Exclusive Content #Opinion #Trends & Analysis

DNA sequencing
#Collaboration #Genetics / genomics #Genome sequencing #High throughput screening #Lab automation #Library screening #Oxford Nanopore Technologies #Partnership #The Tecan Group

Alliance hopes to automate nanopore library preparation

The Tecan Group and Oxford Nanopore Technologies will collaborate to drive easier high throughput nanopore library preparation in an automated, hands-free fashion.   The aim of the partnership is a fully automated workflow for Oxford Nanopore’s Ligation Sequencing Kit XL V14 protocol (LSK114) with Tecan’s DreamPrep NGS solutions. Read More

#Business & Investment #News

Genomics
#Biotechnology #Comment #Data #Gene editing #Genetics / genomics #Genome sequencing #Healthcare #Public health #Research #Whole genome sequencing

Why genomic healthcare data matters in the development of new therapies 

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact.  The origins  One might… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Antimicrobial resistance (AMR) #Genetics / genomics #Genome sequencing #Pandemic

Q&A: Gene therapy opportunities from long-read sequencing 

Breakthroughs in gene therapy are only possible with an exact understanding of the genetic underpinnings of disease. To develop safe and effective gene therapies, researchers need confidence that genomic data is both complete and accurate. Here, DDW Editor Reece Armstrong speaks to Neil Ward, General Manager and VP at… Read More

#Exclusive Content

#Assays #Genetics / genomics #Genome sequencing

Genome sequencing assays for infectious disease surveillance

“Viruses evolve — that’s a fact of life”, says Dr Nick Downey (NGS collaborations lead, Integrated DNA Technologies), Dr Nikki Freed (Auckland Genomics, University of Auckland, New Zealand) and Dr Olin Silander (School of Natural and Computational Sciences, Massey University, New Zealand) in this DDW exclusive. Every time a virus replicates itself, there… Read More

#Editor's Choice #Exclusive Content #News

#Genome sequencing #Genomics #Podcasts

Podcast: What can we learn from the genome?  

This is the latest episode of the free DDW podcast, “What can we learn from the genome?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW and read aloud by Megan Thomas.   The articles are called “Reproducibility in single cell… Read More

#News #Trending News

#Drug discovery #Gene sequencing #Genome sequencing #Sequencing

Macrogen Europe expands sequencing capacity

Genomic sequencing service provider Macrogen Europe has achieved an upgrade to its next generation sequencing (NGS) capacity. The installation of an additional Illumina NovaSeq 6000 high-throughput sequencing system in its headquarters in the Netherlands helps manage increased demand with high-quality results and fast, reliable turnaround times. The addition of the… Read More

#News